Allogene疗法(ALLO)

5.02 -0.03 -0.5941%

今开:4.99昨收:5.05
最高:5.06 最低:4.905
涨停价:0.0跌停价:0.0
总市值:7.25376863E8

Allogene疗法的热门评论

Allogene疗法(ALLO)2019-11-22 05:45

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001214659-19-007333 Size: 6 KB 网页链接查看全文

Allogene疗法(ALLO)2020-12-19 07:36

$Allogene疗法(ALLO)$ 内部交易: 2020-12-17,General Counsel,Bhavnagri Veer ,期权,51500普通股, $2.27查看全文

Allogene疗法(ALLO)2020-12-19 05:36

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001214659-20-010544 Size: 6 KB 网页链接查看全文

Allogene疗法(ALLO)2019-11-06 20:40

$Allogene疗法(ALLO)$ 8-K - Current report Filed: 2019-11-05 AccNo: 0001737287-19-000023 Size: 40 KBItem 1.01: Entry into a Material Definitive Agreement 网页链接查看全文

Allogene疗法(ALLO)2020-12-15 21:36

$Allogene疗法(ALLO)$ 8-K Current report, item 1.01 Accession Number: 0001737287-20-000064 Act: 34 Size: 182 KB 网页链接查看全文

Allogene疗法(ALLO)2020-12-07 21:37

$Allogene疗法(ALLO)$ 8-K Current report, item 8.01 Accession Number: 0001737287-20-000061 Act: 34 Size: 216 KB 网页链接查看全文

Allogene疗法(ALLO)2019-11-06 20:40

$Allogene疗法(ALLO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-11-05 AccNo: 0001737287-19-000020 Size: 6 MB 网页链接查看全文

Allogene疗法(ALLO)2019-11-05 20:50

$Allogene疗法(ALLO)$ 8-K - Current report Filed: 2019-11-05 AccNo: 0001737287-19-000016 Size: 119 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Allogene疗法(ALLO)2020-11-19 05:42

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001214659-20-009726 Size: 8 KB 网页链接查看全文

chuminhua2020-11-05 17:10

11/4, Allogene Therapeutics表示,将于下月在美国血液学会(ASH)会议上公布的I期UNIVERSAL研究结果显示,其抗BCMA异体CAR-T疗法ALLO-715在重度预处理的多发性骨髓瘤患者中具有剂量依赖性的活性,包括最高剂量下总体反应率(ORR)60%。$Allogene疗法(ALLO)$查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39

Allogene疗法的最新评论

持股变动声明

Allogene疗法(ALLO)03-25 08:27

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000529 Size: 7 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)03-25 08:21

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000523 Size: 10 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)03-25 08:21

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000527 Size: 8 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)03-25 08:21

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000525 Size: 5 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)03-25 08:18

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000521 Size: 10 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)03-17 05:36

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000025 Size: 8 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)03-17 05:12

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000024 Size: 6 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)03-17 04:57

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000492 Size: 5 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)03-17 04:51

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000491 Size: 5 KB 网页链接查看全文

当期报告

Allogene疗法(ALLO)03-11 05:06

$Allogene疗法(ALLO)$ 8-K Current report, item 7.01 Accession Number: 0001737287-23-000023 Act: 34 Size: 165 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39

Allogene疗法的公告

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000529 Size: 7 KB 网页链接

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000523 Size: 10 KB 网页链接

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000525 Size: 5 KB 网页链接

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000527 Size: 8 KB 网页链接

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000521 Size: 10 KB 网页链接

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000025 Size: 8 KB 网页链接

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000024 Size: 6 KB 网页链接

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000492 Size: 5 KB 网页链接

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000491 Size: 5 KB 网页链接

当期报告

$Allogene疗法(ALLO)$ 8-K Current report, item 7.01 Accession Number: 0001737287-23-000023 Act: 34 Size: 165 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29